By determining the target of inflammation in the joint and the distribution of affected joints, a clinician can distinguish among non-inflammatory arthritis (osteoarthritis), other non-inflammatory rheumatic conditions (like fibromyalgia), and inflammatory conditions such as inflammatory synovitis (rheumatoid arthritis) and inflammatory enthesitis (ankylosing spondylitis, psoriatic arthritis). Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8, 2020, and they are subject to change as new information is published.

Whether we realize it or not, the stories we witness and the narratives we are privileged to co-author give meaning to our work as clinicians. However, stress and burnout prevent many from connecting with these stories. This session will provide the unique perspectives of three different speakers who will discuss storytelling, the “4Rs” (reflection, relationships, resourcefulness, and resilience), and fiscal health. From them, you will learn preemptive approaches for managing stress and promoting resilience as well as strategies to obtain non-medical income streams that could put you in position for a more optimal work-life balance. With these tools, you may find more bandwidth to engage with the stories of your patients and restore satisfaction in your work.

This rapid-fire, case-based presentation will discuss the guidelines, controversies, and complexities of hypertension management.

This lecture will focus on the problem of chronic pain, its burden on the patient, and the societal consequences that result from mismanagement. The faculty will present strategies for pharmacologic (opioid and non-opioid) and nonpharmacologic management of chronic pain and the evidence behind them. With improved insight into controlling and managing opioid therapy as well as medication-assisted treatment for opioid use disorder, you can help protect your patients from the opioid epidemic. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8, 2020, and they are subject to change as new information is published.

This lecture will focus on known and established pathogenesis of HIV, emphasizing the damage to the immune system as well as illnesses that primary care clinicians may encounter. With expanded knowledge of therapeutic strategies to regain and maintain health, you can address complications that arise with your patients and recognize when to refer. The faculty will also discuss issues that an aging HIV population may face and how to treat them. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 2/8/2020, and they are subject to change as new information is published.

This lecture will address five common but challenging issues in primary care practice including the cause of a patient's red eye, the cause of a patient's pathologic headache, whether a patient is depressed or suicidal, whether a patient has endocarditis, and causes of a patient's back pain.

The amount of information available in the form of clinical trials and cohort studies is overwhelming, especially for primary care clinicians. Moreover, practice guidelines do not always reflect what is feasible or even best practice in specific clinical settings. This session will highlight some of the strongest research and guidelines that may alter clinical practice, with a focus on literature published in the past year. Every participant should take away several practical points that help them provide better patient care. The session will have an interactive component, which will allow for different perspectives and collective wisdom to make the best use of current evidence.

This talk will focus on several common and confusing topics and scenarios that often arise in the primary care practice setting. The faculty will review an approach to patients who come into the clinic with a diagnosis of asthma for whom the clinical suspicion is low that includes spirometry and methacholine challenge interpretation. Next, the talk will cover the evidence for using long-term oxygen therapy in respiratory patients and the various oxygen delivery systems. The faculty will also discuss the approach to chronic cough when typical therapies have failed to improve systems as well as current evidence and approach to lung cancer screening. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 2/6/2020 and they are subject to change as new information is published.

This talk on deep vein thrombosis (DVT) will review common clinical presentations, diagnostic workup, indications for imaging, and therapeutic options. The consequences of DVT, such as pulmonary embolism and stroke (in patients with patent foramen ovale), can be dire, and the faculty will provide strategies to reduce morbidity and mortality. You will dive into a detailed lesson on the medical therapy for DVT, which includes anticoagulation strategies using warfarin or the novel factor Xa inhibitors. After this session, you will know when to refer for more advanced invasive therapies and have insight into management of special populations. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 9th, 2020, and they are subject to change as new information is published.

This program is designed to address some of the practical clinical issues from the recent literature. You will learn about controversies and caveats that will help you interpret recent updates. A few case examples of routine practice encounters will illustrate how to apply this new information in daily practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 9, 2020, and they are subject to change as new information is published.

Initial findings of the Women’s Health Initiative (WHI) published in 2002 forever changed the way menopause hormone therapy has been viewed in the United States. After WHI, use of systemic menopause hormone therapy (MHT) decreased by as much as 80 percent among U.S. women. In the following decade and half, additional data derived from WHI coupled with new research findings resulted in confusion and misunderstandings for patients and clinicians alike on the appropriate use of MHT to manage menopause. This presentation will blend the findings of WHI with newer learnings and provide a practical approach to using MHT.